-
Something wrong with this record ?
Harnessing the combined effect of antivirulence agent trans-chalcone with bactericidal curcumin against sortase A enzyme to tackle Gram-positive bacterial infections
P. Kumari, SK. Banerjee, US. Murty, V. Ravichandiran, U. Mohan
Status minimal Language English Country Czech Republic
Document type Journal Article
- MeSH
- Aminoacyltransferases * antagonists & inhibitors metabolism MeSH
- Anti-Bacterial Agents * pharmacology chemistry MeSH
- Bacterial Proteins * metabolism antagonists & inhibitors MeSH
- Biofilms * drug effects MeSH
- Chalcone * pharmacology chemistry MeSH
- Cysteine Endopeptidases * metabolism MeSH
- Virulence Factors metabolism MeSH
- Gram-Positive Bacterial Infections drug therapy microbiology MeSH
- Gram-Positive Bacteria drug effects MeSH
- Curcumin * pharmacology chemistry MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Virulence drug effects MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Gram-positive bacteria are responsible for a wide range of infections in humans. In most Gram-positive bacteria, sortase A plays a significant role in attaching virulence factors to the bacteria's cell wall. These cell surface proteins play a significant role in virulence and pathogenesis. Even though antibiotics are available to treat these infections, there is a continuous search for an alternative strategy due to an increase in antibiotic resistance. Thus, using anti-sortase drugs to combat these bacterial infections may be a promising approach. Here, we describe a method for targeting Gram-positive bacterial infection by combining curcumin and trans-chalcone as sortase A inhibitors. We have used curcumin and trans-chalcone alone and in combination as a sortase A inhibitor. We have seen ~78%, ~43%, and ~94% inhibition when treated with curcumin, trans-chalcone, and a combination of both compounds, respectively. The compounds have also shown a significant effect on biofilm formation, IgG binding, protein A recruitment, and IgG deposition. We discovered that combining curcumin and trans-chalcone is more effective against Gram-positive bacteria than either compound alone. The present work demonstrated that a combination of these natural compounds could be used as an antivirulence therapy against Gram-positive bacterial infection.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24009814
- 003
- CZ-PrNML
- 005
- 20240606085139.0
- 007
- ta
- 008
- 240606s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-023-01097-1 $2 doi
- 035 __
- $a (PubMed)37930610
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kumari, Poonam $u Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, 781101, India
- 245 10
- $a Harnessing the combined effect of antivirulence agent trans-chalcone with bactericidal curcumin against sortase A enzyme to tackle Gram-positive bacterial infections / $c P. Kumari, SK. Banerjee, US. Murty, V. Ravichandiran, U. Mohan
- 520 9_
- $a Gram-positive bacteria are responsible for a wide range of infections in humans. In most Gram-positive bacteria, sortase A plays a significant role in attaching virulence factors to the bacteria's cell wall. These cell surface proteins play a significant role in virulence and pathogenesis. Even though antibiotics are available to treat these infections, there is a continuous search for an alternative strategy due to an increase in antibiotic resistance. Thus, using anti-sortase drugs to combat these bacterial infections may be a promising approach. Here, we describe a method for targeting Gram-positive bacterial infection by combining curcumin and trans-chalcone as sortase A inhibitors. We have used curcumin and trans-chalcone alone and in combination as a sortase A inhibitor. We have seen ~78%, ~43%, and ~94% inhibition when treated with curcumin, trans-chalcone, and a combination of both compounds, respectively. The compounds have also shown a significant effect on biofilm formation, IgG binding, protein A recruitment, and IgG deposition. We discovered that combining curcumin and trans-chalcone is more effective against Gram-positive bacteria than either compound alone. The present work demonstrated that a combination of these natural compounds could be used as an antivirulence therapy against Gram-positive bacterial infection.
- 650 12
- $a kurkumin $x farmakologie $x chemie $7 D003474
- 650 12
- $a cysteinové endopeptidasy $x metabolismus $7 D003546
- 650 12
- $a aminoacyltransferasy $x antagonisté a inhibitory $x metabolismus $7 D019881
- 650 12
- $a bakteriální proteiny $x metabolismus $x antagonisté a inhibitory $7 D001426
- 650 12
- $a antibakteriální látky $x farmakologie $x chemie $7 D000900
- 650 12
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chalkon $x farmakologie $x chemie $7 D002599
- 650 _2
- $a grampozitivní bakterie $x účinky léků $7 D006094
- 650 _2
- $a grampozitivní bakteriální infekce $x farmakoterapie $x mikrobiologie $7 D016908
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a virulence $x účinky léků $7 D014774
- 650 _2
- $a faktory virulence $x metabolismus $7 D037521
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Banerjee, Sanjay K $u Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, 781101, India
- 700 1_
- $a Murty, Upadhyayula Surayanarayana $u Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, 781101, India
- 700 1_
- $a Ravichandiran, Velayutham $u Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, 700054, India
- 700 1_
- $a Mohan, Utpal $u Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, 700054, India. mohan.utpal@gmail.com $1 https://orcid.org/0000000202567305
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 69, č. 3 (2024), s. 639-652
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37930610 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240606 $b ABA008
- 991 __
- $a 20240606085133 $b ABA008
- 999 __
- $a min $b bmc $g 2102565 $s 1219644
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 69 $c 3 $d 639-652 $e 20231106 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20240606